
Opinion|Videos|March 21, 2025
Managing Adverse Events With Trastuzumab Deruxtecan: Early Detection and ILD Monitoring Strategies
Experts discuss the most common adverse events associated with trastuzumab deruxtecan, how to effectively identify and manage them to minimize treatment interruptions, and how to monitor and address interstitial lung disease (ILD), a known potential adverse effect of trastuzumab deruxtecan.
Advertisement
Episodes in this series

Video content above is prompted by the following:
• What are the most common adverse events associated with trastuzumab deruxtecan, and how can they be effectively identified and managed to minimize treatment interruptions?
• How do you monitor and address ILD, a known potential adverse effect of trastuzumab deruxtecan?
Advertisement
Related to this article

ASTRO 2026 presenter Kayla Kafka-Peterson details an Adapt-Adopt-Build model to bridge global brachytherapy nursing gaps and standardize perioperative care.

At ASTRO 2026, Dr. Nitin Ohri details additive versus synergistic toxicities when combining radiation with novel systemic therapies in clinical trials.

APHON 2026 speaker Amy C. Haskamp, CNS, discusses tiered self-care tactics and boundaries to help pediatric oncology nurses navigate emotional distress and burnout.

At ASTRO 2026, DJohn Hillson details how early post-surgical radiation education within 6 weeks improves outcomes for head and neck cancer patients.

Jyoti Malhotra, MD, MPH, joins The Moonlight Shift to discuss first-in-human phase 1 lung cancer trials, healthcare access, and her work at Yale Cancer Center.

Vanderbilt APPs discuss PSA screening, multidisciplinary care, toxicity management, and genetic testing for Prostate Cancer Awareness Month.

ANA President Jennifer Mensik Kennedy outlines systemic nurse fatigue mitigation policies, emphasizing patient safety and acuity across oncology care.
Advertisement
Advertisement
Trending on Oncology Nursing News
1
Outlining Tiered Self-Care Plans for Oncology Nurses
2
On-Body Isatuximab: Clinical Workflows and At-Home Potential in Myeloma
3
FDA Advisory Panel Votes to Approve GRAIL Galleri MCED Screening Test
4
Oncology Nurse Shares Insights From Her Stage 4 Breast Cancer Journey
5

